Rufat Aliyev

Rufat Aliyev

Auto-generated profile, based on publicly available information

Rufat Aliyev

Scientific Research Center, State Security Service Military Hospital, Baku, Azerbaijan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2024 in Urology Case Reports
Verified
Journal Article
Open access
RSRashad Sholan
Rashad Sholan
RARufat Aliyev
Rufat Aliyev
MSMalahat Sultan
Malahat Sultan
AAAnar Almazkhanli
Anar Almazkhanli
SKSavalan Karim
Savalan Karim
JGJalal Gasimov
Jalal Gasimov
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms, commonly found in the uterus and retroperitoneum. Renal PEComas are exceedingly rare, often posing diagnostic challenges due to their resemblance to renal cell carcinoma (RCC) on imaging. We present the case of an 18-year-old male who presented with non-specific symptoms of fever, chills, and shivering. Imaging revealed a renal mass, initially suspected to be RCC. However, following a right radical nephrectomy, histopathological examination confirmed the diagnosis of malignant PEComa. This case highlights the rarity of renal PEComa and underscores the importance of early diagnosis and appropriate surgical management to prevent complications.

11 May 2025 in Urologia Internationalis
Verified
Journal Article
Closed access
RSRashad Sholan
Rashad Sholan
RARufat Aliyev
Rufat Aliyev
SKSeymur Karimov
Seymur Karimov
MSMalahat Sultan
Malahat Sultan
AAAnar Almazkhanli
Anar Almazkhanli
Introduction: Erectile dysfunction (ED) is a common complication following radical prostatectomy (RP). Although phosphodiesterase type 5 inhibitors (PDE5is) are used for penile rehabilitation, their efficacy post-RP is limited. Low-intensity extracorporeal shockwave therapy (Li-ESWT) has emerged as a potential noninvasive treatment, promoting tissue regeneration. This study evaluates the effectiveness of Li-ESWT, with or without PDE5i, for post-RP ED. Methods: This prospective study included 104 patients who underwent nerve-sparing RP and received Li-ESWT. Patients were divided into two groups: group 1 received daily 5 mg tadalafil along with Li-ESWT, while group 2 received Li-ESWT alone. Erectile function was assessed using the International Index of Erectile Function (IIEF-5) at baseline, 6, 12, and 24 months postoperatively. Results: The preoperative mean IIEF-5 score was 15.7 ± 4.7, with 54.8% of patients scoring below 17. Postoperatively, significant improvements in IIEF-5 scores were observed at 12 and 24 months in both groups compared to the 6th month. In patients with preoperative IIEF-5 <17, group 1 showed significantly greater improvement in IIEF-5 scores compared to group 2 (p = 0.008). No significant difference was observed between the groups in patients with preoperative IIEF-5 ≥17 (p = 0.893). Conclusion: Li-ESWT is an effective treatment for ED following nerve-sparing RP, with or without PDE5i. In patients with mild-to-moderate or greater preoperative ED, the combination of PDE5i and Li-ESWT may provide additional benefits, whereas Li-ESWT alone appears sufficient for those with milder cases.

4 September 2026 in Formosan Journal of Surgery
Verified
Journal Article
Open access
RSRashad Sholan
Rashad Sholan
RARufat Aliyev
Rufat Aliyev
Ulduz HashimovaUlduz Hashimova
Ulduz Hashimova
SKSeymur Karimov
Seymur Karimov
AAAnar Almazkhanli
Anar Almazkhanli
NMNarmin Mammadova
Narmin Mammadova
Background: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition causing persistent bladder-related pain, pressure, or discomfort, significantly impairing quality of life. Cystectomy is a last-resort treatment for severe, refractory cases, but data on outcomes, particularly from specific regions, remain limited. Materials and Methods: This retrospective cohort study analyzed 16 Azerbaijani IC/BPS patients who underwent supratrigonal or total cystectomy between 2014 and 2024. Clinical, radiological, and surgical data were collected, with symptom severity assessed preoperatively and three months postoperatively using the interstitial cystitis symptom index (ICSI), interstitial cystitis problem index (ICPI), and visual analog scale (VAS) for pain. Results: The median age was 57 years, with 75% female. Median symptom duration was 8 years (range: 3-12), anesthetic bladder capacity was 75 mL (range: 40-140), and all patients had Hunner lesions. Surgical interventions included supratrigonal cystectomy with ileal augmentation (12.5%) and simple cystectomy with Bricker ileal conduit diversion (87.5%). Median ICSI scores reduced from 17 (range: 15–19) to 6 (range: 4–8), ICPI from 13 (range: 12–16) to 5 (range: 4–9), and VAS pain scores from 9 (range: 8–10) to 4 (range: 3–5) at the third postoperative month (all p < 0.001). No perioperative complications or in-hospital mortalities occurred, with a median hospital stay of 7 days (range: 6-11). Conclusions: Cystectomy provided substantial symptomatic relief and improved quality-of-life indices in patients with severe, refractory IC/BPS. These findings underscore its role as an effective but complex treatment option for carefully selected patients.

1 January 2026 in Prostate Cancer
Verified
Journal Article
Open access
RSRashad Sholan
Rashad Sholan
RARufat Aliyev
Rufat Aliyev
Ulduz HashimovaUlduz Hashimova
Ulduz Hashimova
SKSeymur Karimov
Seymur Karimov
EBElvin Bayramov
Elvin Bayramov
Background: Prostate‐specific antigen (PSA) levels are influenced by demographic and ethnic factors, but data from Azerbaijani men remain limited. PSA screening for prostate cancer must consider regional and ethnic variations. This study aimed to describe PSA levels and examine their clinical correlates in a hospital‐based cohort of Azerbaijani men presenting to a urology clinic. Methods: This retrospective cross‐sectional study included 1175 Azerbaijani men aged 40–75 years who presented to a urology clinic without a known diagnosis of prostate cancer between January 2023 and December 2024. Data collected included age, total PSA, digital rectal examination (DRE)–estimated prostate size category, prostate volume (via ultrasound), maximum urinary flow rate ( Q max ), and International Prostate Symptom Score (IPSS). Multivariate logistic regression was used to identify predictors of PSA elevation. Results: The median PSA level was 1.15 ng/mL (range: 0.001–112.1), with 85.1% of patients exhibiting levels below 4 ng/mL. PSA levels increased with age: 0.86 ng/mL in men aged 40–49, 1.2 ng/mL in those 50–64, and 1.44 ng/mL in men 65–75 years ( p < 0.001). PSA correlated positively with age, IPSS, and prostate volume and negatively with Q max (all p < 0.001). PSA levels varied with DRE‐estimated prostate size category, showing significant differences between Categories 2 and 3 ( p = 0.002). Multivariate analysis identified age as an independent predictor of PSA ≥ 4 ng/mL. Conclusions: In this hospital‐based cohort of Azerbaijani men, PSA levels were positively associated with age, and age was independently associated with PSA ≥ 4 ng/mL. These findings provide important regional data and support further investigation of age‐specific PSA patterns in the Azerbaijani population.

17 November 2024 in Urology Reports (St. - Petersburg)
Verified
Journal Article
Closed access
PDF file
RSRashad Sholan
Rashad Sholan
RARufat Aliyev
Rufat Aliyev
Ulduz HashimovaUlduz Hashimova
Ulduz Hashimova
AAAnar Almazkhanli
Anar Almazkhanli
NBNergiz Bakhsheliyeva
Nergiz Bakhsheliyeva
МНМамедова Нармин
Мамедова Нармин
BACKGROUND: Kidney transplantation is a recognized method of treating patients with end–stage kidney disease. However, the risk of graft loss is not excluded. In Azerbaijan, kidney transplantation is mainly performed from living donors; nevertheless, there is little data on the panel-reactive antibodies (PRA) and its use in the transplantation program. AIM: To evaluate the prevalence of positive panel-reactive antibodies (PRA) and short-term outcomes of living donor kidney transplantation. MATERIALS AND METHODS: Within 6 months after kidney transplantation, 113 recipients were followed up. All patients underwent their first transplantation. Complement-dependent cytotoxicity cross-matching, HLA typing, and flow cytometry cross-matching were carried out. Flow cytometric analysis was applied to detect PRA. The positive response percentage is presented by the percentage of events shifted to the right of the cutoff point. Data were analyzed using SPSS 16.0 statistical software. RESULTS: Among the examined patients, men predominated. In PRA-positive patients (n = 20), the dialysis duration was on average 22.3% longer than in PRA-negative patients (n = 93). 35.0% of PRA-positive patients had class I PRA, 30.0% of patients had class II PRA, and 35.0% had class I + II PRA. In 40.0% of cases, positive PRA had high sensitization 50% (predominantly class II), and the remaining 60.0% had PRA from 10% to 50%. Sensitizing factors were more common in the PRA-positive group (p 0.05). After 6 months of folow-up, the mean creatinine level was 183.4 ± 68.84 nmol/l in the PRA-positive group and 198.15 ± 108.23 nmol/l in the PRA-negative group (p = 0.91). The overall emptying rate was 4.4% (n = 5), with all 5 cases being in the PRA-negative group. No deaths were observed during the follow-up period. CONCLUSIONS: PRA positive patients usually have some sensitizing event such as pregnancy or blood transfusion. The transfusion itself was not a significant factor of sensitization in this study. Patients with high PRA levels require more thorough examination.

1 January 2025 in Case Reports in Medicine
Verified
Journal Article
Open access
RSRashad Sholan
Rashad Sholan
RARufat Aliyev
Rufat Aliyev
AAAnar Almazkhanli
Anar Almazkhanli
JGJalal Gasimov
Jalal Gasimov
NBNargiz Bakhshaliyeva
Nargiz Bakhshaliyeva
MSMalahat Sultan
Malahat Sultan
Introduction: Interstitial cystitis (IC) is a chronic pelvic pain syndrome characterized by urinary urgency, frequency, and pain. Although the exact cause of IC is unclear, severe cases may lead to chronic kidney disease (CKD), requiring complex surgical interventions. Case Presentation: This case report presents a 46‐year‐old male with IC complicated by CKD secondary to total urethral stricture. Following recurrent surgeries for urinary tract infections and strictures, the patient underwent a staged surgical approach involving bilateral nephrectomy, supratrigonal cystectomy, and renal transplantation with Bricker ileal conduit diversion. Postoperatively, renal function was fully restored, and IC‐related symptoms resolved. Conclusion: This case underscores the efficacy of major surgical interventions for refractory IC, highlighting the need for individualized, multidisciplinary management in complex cases.